Bayer EBITDA 2010-2025 | BAYRY

Bayer EBITDA for the quarter ending March 31, 2025 was $3.685B, a 19.28% decline year-over-year.

  • Bayer 2024 EBITDA was 9.427B, a 18.07% decline from 2023.
  • Bayer 2023 EBITDA was 11.507B, a 19.19% decline from 2022.
  • Bayer 2022 EBITDA was 14.239B, a 87.79% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Bayer EBITDA 2010-2025 | BAYRY

  • Bayer 2024 EBITDA was 9.427B, a 18.07% decline from 2023.
  • Bayer 2023 EBITDA was 11.507B, a 19.19% decline from 2022.
  • Bayer 2022 EBITDA was 14.239B, a 87.79% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$770.2B
Johnson & Johnson (JNJ)$404.9B
AbbVie (ABBV)$336.1B
Novo Nordisk (NVO)$320.1B
Roche Holding AG (RHHBY)$261.4B
Novartis AG (NVS)$248.6B
Merck (MRK)$212.7B
Pfizer (PFE)$140.9B
Sanofi (SNY)$123.5B
Innoviva (INVA)$1.2B